Position in RNA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$529,986
New position
Shares Held
39,640
first reported quarter
Ownership
0.232%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Saba Capital Management, L.P. holds $561,229 across 2 Biotechnology names. RNA ranks #1 (94.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RNA |
Atrium Therapeutics, Inc.
This page
|
39,640 | $529,986 | |
| 2 | OABIW |
OmniAb, Inc.
|
19,900 | $31,243 |
All Filings in RNA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $529,986 | 39,640 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||